The reserpine-sensitive dopamine pool mediates (+)-amphetamine-conditioned reward in the place preference paradigm

Noboru Hiroi, Norman M. White

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

The neural basis of amphetamine-conditioned reward was investigated in the conditioned place preference paradigm. When bilaterally injected into the nucleus accumbens before the test session, a dopamine receptor blocker, α-flupenthixol, blocked the expression of the amphetamine-conditioned place preference. α-Flupenthixol had no significant effect on spontaneous locomotor activity. Bilateral microinjections of a tyrosine hydroxylase inhibitor, α-methyl-p-tyrosine (α-MPT), decreased (+)-amphetamine locomotor stimulation in a dose-dependent fashion. Two doses of α-MPT that completely blocked (+)-amphetamine locomotor stimulation had no effect on the expression of the conditioned place preference when injected into the nucleus accumbens before testing. Reserpine administered subcutaneously before testing blocked the expression of the conditioned place preference. A dose of reserpine (4.0 mg/kg), which completely blocked the conditioned place preference, did not attenuate (+)-amphetamine-induced locomotor stimulation. This dose of reserpine depleted dopamine in the nucleus accumbens to 4% of its normal value. These data show that (+)-amphetamine-conditioned reward, expressed as a conditioned place preference, is mediated by dopamine release in the nucleus accumbens. Moreover, the dopamine is released from the reserpine sensitive pool, and probably not from the newly synthesized α-MPT-sensitive pool.

Original languageEnglish (US)
Pages (from-to)33-42
Number of pages10
JournalBrain Research
Volume510
Issue number1
DOIs
StatePublished - Feb 26 1990
Externally publishedYes

Fingerprint

Reserpine
Amphetamine
Reward
Dopamine
Nucleus Accumbens
Flupenthixol
Dopamine Antagonists
Dopamine Receptors
Tyrosine 3-Monooxygenase
Microinjections
Locomotion
Tyrosine
Reference Values

Keywords

  • (+)-Amphetamine
  • Conditioned place preference
  • Conditioned reinforcement
  • Conditioned reward
  • Dopamine
  • Dopamine pool
  • Locomotor activity
  • Nucleus accumbens
  • Reserpine
  • Reward
  • α-Flupenthixol
  • α-Methyl-p-tyrosine

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

The reserpine-sensitive dopamine pool mediates (+)-amphetamine-conditioned reward in the place preference paradigm. / Hiroi, Noboru; White, Norman M.

In: Brain Research, Vol. 510, No. 1, 26.02.1990, p. 33-42.

Research output: Contribution to journalArticle

@article{2d0ebb8a83fe46389dc7dffb18868bc0,
title = "The reserpine-sensitive dopamine pool mediates (+)-amphetamine-conditioned reward in the place preference paradigm",
abstract = "The neural basis of amphetamine-conditioned reward was investigated in the conditioned place preference paradigm. When bilaterally injected into the nucleus accumbens before the test session, a dopamine receptor blocker, α-flupenthixol, blocked the expression of the amphetamine-conditioned place preference. α-Flupenthixol had no significant effect on spontaneous locomotor activity. Bilateral microinjections of a tyrosine hydroxylase inhibitor, α-methyl-p-tyrosine (α-MPT), decreased (+)-amphetamine locomotor stimulation in a dose-dependent fashion. Two doses of α-MPT that completely blocked (+)-amphetamine locomotor stimulation had no effect on the expression of the conditioned place preference when injected into the nucleus accumbens before testing. Reserpine administered subcutaneously before testing blocked the expression of the conditioned place preference. A dose of reserpine (4.0 mg/kg), which completely blocked the conditioned place preference, did not attenuate (+)-amphetamine-induced locomotor stimulation. This dose of reserpine depleted dopamine in the nucleus accumbens to 4{\%} of its normal value. These data show that (+)-amphetamine-conditioned reward, expressed as a conditioned place preference, is mediated by dopamine release in the nucleus accumbens. Moreover, the dopamine is released from the reserpine sensitive pool, and probably not from the newly synthesized α-MPT-sensitive pool.",
keywords = "(+)-Amphetamine, Conditioned place preference, Conditioned reinforcement, Conditioned reward, Dopamine, Dopamine pool, Locomotor activity, Nucleus accumbens, Reserpine, Reward, α-Flupenthixol, α-Methyl-p-tyrosine",
author = "Noboru Hiroi and White, {Norman M.}",
year = "1990",
month = "2",
day = "26",
doi = "10.1016/0006-8993(90)90724-P",
language = "English (US)",
volume = "510",
pages = "33--42",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - The reserpine-sensitive dopamine pool mediates (+)-amphetamine-conditioned reward in the place preference paradigm

AU - Hiroi, Noboru

AU - White, Norman M.

PY - 1990/2/26

Y1 - 1990/2/26

N2 - The neural basis of amphetamine-conditioned reward was investigated in the conditioned place preference paradigm. When bilaterally injected into the nucleus accumbens before the test session, a dopamine receptor blocker, α-flupenthixol, blocked the expression of the amphetamine-conditioned place preference. α-Flupenthixol had no significant effect on spontaneous locomotor activity. Bilateral microinjections of a tyrosine hydroxylase inhibitor, α-methyl-p-tyrosine (α-MPT), decreased (+)-amphetamine locomotor stimulation in a dose-dependent fashion. Two doses of α-MPT that completely blocked (+)-amphetamine locomotor stimulation had no effect on the expression of the conditioned place preference when injected into the nucleus accumbens before testing. Reserpine administered subcutaneously before testing blocked the expression of the conditioned place preference. A dose of reserpine (4.0 mg/kg), which completely blocked the conditioned place preference, did not attenuate (+)-amphetamine-induced locomotor stimulation. This dose of reserpine depleted dopamine in the nucleus accumbens to 4% of its normal value. These data show that (+)-amphetamine-conditioned reward, expressed as a conditioned place preference, is mediated by dopamine release in the nucleus accumbens. Moreover, the dopamine is released from the reserpine sensitive pool, and probably not from the newly synthesized α-MPT-sensitive pool.

AB - The neural basis of amphetamine-conditioned reward was investigated in the conditioned place preference paradigm. When bilaterally injected into the nucleus accumbens before the test session, a dopamine receptor blocker, α-flupenthixol, blocked the expression of the amphetamine-conditioned place preference. α-Flupenthixol had no significant effect on spontaneous locomotor activity. Bilateral microinjections of a tyrosine hydroxylase inhibitor, α-methyl-p-tyrosine (α-MPT), decreased (+)-amphetamine locomotor stimulation in a dose-dependent fashion. Two doses of α-MPT that completely blocked (+)-amphetamine locomotor stimulation had no effect on the expression of the conditioned place preference when injected into the nucleus accumbens before testing. Reserpine administered subcutaneously before testing blocked the expression of the conditioned place preference. A dose of reserpine (4.0 mg/kg), which completely blocked the conditioned place preference, did not attenuate (+)-amphetamine-induced locomotor stimulation. This dose of reserpine depleted dopamine in the nucleus accumbens to 4% of its normal value. These data show that (+)-amphetamine-conditioned reward, expressed as a conditioned place preference, is mediated by dopamine release in the nucleus accumbens. Moreover, the dopamine is released from the reserpine sensitive pool, and probably not from the newly synthesized α-MPT-sensitive pool.

KW - (+)-Amphetamine

KW - Conditioned place preference

KW - Conditioned reinforcement

KW - Conditioned reward

KW - Dopamine

KW - Dopamine pool

KW - Locomotor activity

KW - Nucleus accumbens

KW - Reserpine

KW - Reward

KW - α-Flupenthixol

KW - α-Methyl-p-tyrosine

UR - http://www.scopus.com/inward/record.url?scp=0025124431&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025124431&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(90)90724-P

DO - 10.1016/0006-8993(90)90724-P

M3 - Article

C2 - 2322845

AN - SCOPUS:0025124431

VL - 510

SP - 33

EP - 42

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1

ER -